Tailored chemotherapy: Innovative deep-learning model customizing chemotherapy for high-grade serous ovarian carcinoma.

Journal: Clinical and translational medicine
PMID:

Abstract

No abstract available for this article.

Authors

  • Se Ik Kim
    Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Sangick Park
    Department of Advanced Convergence, Handong Global University, Pohang-si 37554, Gyeongbuk, Korea.
  • Eunyong Ahn
    Research Group, Foretell My Health, Pohang, South Korea.
  • Jeunhui Kim
    Department of Advanced Green Energy and Environment, Handong Global University, Pohang, South Korea.
  • HyunA Jo
    Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Juwon Lee
    Department of Control and Instrumentation Engineering, Korea University, 2511 Sejong-ro, Sejong-City 30019, Korea.
  • Untack Cho
    Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Maria Lee
    Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Cheol Lee
    Department of Pathology, Seoul National University Hospital, Seoul, Korea.
  • Danny N Dhanasekaran
    Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • TaeJin Ahn
    Department of Life Sciences, Handong Global University, Pohang 37554, Korea.
  • Yong Sang Song
    Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: yssong@snu.ac.kr.